Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi

NCT03130426 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: iGlarLixi
DRUG: Insulin Glargine
DRUG: Metformin
BEHAVIORAL: Lifestyle therapy

Sponsor

Population Health Research Institute

Collaborators

[object Object]